Concepedia

Publication | Open Access

Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

DOIFull Paper Access

161

Citations

16

References

2008

Year

Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilâ, Mads Rauning Buhl, Kristine Mφrch, Amar P. Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin,
Hepatology

Abstract

Peginterferon/ribavirin treatment for 12 weeks in HCV genotype 2/3 infection is overall inferior to 24 weeks of treatment but may be useful in some patients with a rapid initial clearance of virus.

References

YearCitations

Page 1